• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

幽门螺杆菌感染的根除治疗:其在预防胃癌发生中的重要性及可能的关系。

Eradication Treatment of Helicobacter pylori Infection: Its Importance and Possible Relationship in Preventing the Development of Gastric Cancer.

作者信息

Roesler Bruna Maria, Costa Sandra Cecília Botelho, Zeitune José Murilo Robilotta

机构信息

Department of Clinical Medicine, Faculty of Medical Sciences, State University of Campinas (UNICAMP), 13.081-970 Campinas, SP, Brazil.

出版信息

ISRN Gastroenterol. 2012;2012:935410. doi: 10.5402/2012/935410. Epub 2012 Jun 13.

DOI:10.5402/2012/935410
PMID:22778979
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3384894/
Abstract

Helicobacter pylori is the most important carcinogen for gastric adenocarcinoma. Bacterial virulence factors are essential players in modulating the immune response involved in the initiation of carcinogenesis in the stomach; host genetic factors contribute to the regulation of the inflammatory response and to the aggravation of mucosal damage. In terms of environmental factors, salt intake and smoking contribute to the development of lesions. Various therapeutic schemes are proposed to eradicate H. pylori infection, which could potentially prevent gastric cancer, offering the greatest benefit if performed before premalignant changes of the gastric mucosa have occurred.

摘要

幽门螺杆菌是胃腺癌最重要的致癌物。细菌毒力因子是调节参与胃癌发生起始阶段免疫反应的关键因素;宿主遗传因素有助于调节炎症反应并加剧黏膜损伤。在环境因素方面,盐摄入和吸烟会促使病变发展。人们提出了各种治疗方案来根除幽门螺杆菌感染,这有可能预防胃癌,若在胃黏膜发生癌前病变之前进行根除治疗,则益处最大。

相似文献

1
Eradication Treatment of Helicobacter pylori Infection: Its Importance and Possible Relationship in Preventing the Development of Gastric Cancer.幽门螺杆菌感染的根除治疗:其在预防胃癌发生中的重要性及可能的关系。
ISRN Gastroenterol. 2012;2012:935410. doi: 10.5402/2012/935410. Epub 2012 Jun 13.
2
Gastric carcinogenesis.胃癌发生。
Langenbecks Arch Surg. 2011 Aug;396(6):729-42. doi: 10.1007/s00423-011-0810-y. Epub 2011 May 25.
3
Host genetic factors respond to pathogenic step-specific virulence factors of Helicobacter pylori in gastric carcinogenesis.宿主遗传因素对幽门螺杆菌在胃癌发生过程中特定于致病步骤的毒力因子作出反应。
Mutat Res Rev Mutat Res. 2014 Jan-Mar;759:14-26. doi: 10.1016/j.mrrev.2013.09.002. Epub 2013 Sep 25.
4
Host pathogen interactions in related gastric cancer.相关胃癌中的宿主-病原体相互作用
World J Gastroenterol. 2017 Mar 7;23(9):1521-1540. doi: 10.3748/wjg.v23.i9.1521.
5
Helicobacter pylori in gastric carcinogenesis.幽门螺杆菌与胃癌发生
World J Gastrointest Oncol. 2015 Dec 15;7(12):455-65. doi: 10.4251/wjgo.v7.i12.455.
6
Pathways of Gastric Carcinogenesis, Virulence and Interactions with Antioxidant Systems, Vitamin C and Phytochemicals.胃癌发生的途径、毒力及其与抗氧化系统、维生素 C 和植物化学物质的相互作用。
Int J Mol Sci. 2020 Sep 3;21(17):6451. doi: 10.3390/ijms21176451.
7
Does eradication of Helicobacter pylori reduce the risk of carcinogenesis in the residual stomach after gastrectomy for early gastric cancer? Comparison of mucosal lesions in the residual stomach before and after Helicobacter pylori eradication.根除幽门螺杆菌是否能降低早期胃癌胃切除术后残胃的癌变风险?幽门螺杆菌根除前后残胃黏膜病变的比较。
Langenbecks Arch Surg. 2004 Apr;389(2):83-91. doi: 10.1007/s00423-003-0451-x. Epub 2004 Feb 6.
8
Gastrointestinal microbiome and : Eradicate, leave it as it is, or take a personalized benefit-risk approach?胃肠道微生物组与:根除、保留原状,还是采取个体化的获益-风险方法?
World J Gastroenterol. 2022 Feb 21;28(7):766-774. doi: 10.3748/wjg.v28.i7.766.
9
[Croatian guidelines for gastric cancer prevention by eradication of Helicobacter pylori infection].[克罗地亚根除幽门螺杆菌感染预防胃癌指南]
Lijec Vjesn. 2014 Mar-Apr;136(3-4):59-68.
10
Helicobacter pylori infection: host immune response, implications on gene expression and microRNAs.幽门螺杆菌感染:宿主免疫反应、对基因表达和微小RNA的影响
World J Gastroenterol. 2014 Feb 14;20(6):1424-37. doi: 10.3748/wjg.v20.i6.1424.

引用本文的文献

1
PCR-based RFLP and ERIC-PCR patterns of Helicobacter pylori strains linked to multidrug resistance in Egypt.基于 PCR 的 RFLP 和 ERIC-PCR 图谱显示与埃及多药耐药相关的幽门螺杆菌菌株。
Sci Rep. 2024 Sep 27;14(1):22273. doi: 10.1038/s41598-024-72289-z.
2
Anti-Inflammatory Effect of Korean Propolis on -Infected Gastric Mucosal Injury Mice Model.朝鲜蜂胶对 - 感染性胃黏膜损伤小鼠模型的抗炎作用。
Nutrients. 2022 Nov 3;14(21):4644. doi: 10.3390/nu14214644.
3
Chilean Rhubarb, (Molina) Mirb. (Gunneraceae): UHPLC-ESI-Orbitrap-MS Profiling of Aqueous Extract and its Anti- Activity.智利大黄,(莫利纳)米尔贝。(贡纳尔科属):水提取物的超高效液相色谱-电喷雾电离-轨道阱质谱分析及其抗活性。
Front Pharmacol. 2021 Jan 27;11:583961. doi: 10.3389/fphar.2020.583961. eCollection 2020.
4
Microbes in Tumoral In Situ Tissues and in Tumorigenesis.肿瘤原位组织和肿瘤发生中的微生物。
Front Cell Infect Microbiol. 2020 Nov 24;10:572570. doi: 10.3389/fcimb.2020.572570. eCollection 2020.
5
Effect of β-caryophyllene from Cloves Extract on Eradication in Mouse Model.丁香油中β-石竹烯对清除的影响。
Nutrients. 2020 Apr 4;12(4):1000. doi: 10.3390/nu12041000.
6
Comparing the efficacy of four different protocols for eradicating of Helicobacter pylori infection in Ahvaz, southwest Iran.比较伊朗西南部阿瓦士四种不同根除幽门螺杆菌感染方案的疗效。
Prz Gastroenterol. 2015;10(2):94-9. doi: 10.5114/pg.2015.49001. Epub 2015 Feb 10.
7
Gastric cancer review.胃癌综述。
J Carcinog. 2014 Dec 19;13:14. doi: 10.4103/1477-3163.146506. eCollection 2014.
8
Connexin 32 and 43 promoter methylation in Helicobacter pylori-associated gastric tumorigenesis.幽门螺杆菌相关胃癌发生过程中连接蛋白32和43启动子甲基化
World J Gastroenterol. 2014 Sep 7;20(33):11770-9. doi: 10.3748/wjg.v20.i33.11770.
9
Fluoroquinolone-based protocols for eradication of Helicobacter pylori.基于氟喹诺酮类药物的幽门螺杆菌根除方案。
World J Gastroenterol. 2014 Jul 21;20(27):8947-56. doi: 10.3748/wjg.v20.i27.8947.

本文引用的文献

1
Furazolidone-based therapies for Helicobacter pylori infection: a pooled-data analysis.基于呋喃唑酮的幽门螺杆菌感染治疗:汇总数据分析。
Saudi J Gastroenterol. 2012 Jan-Feb;18(1):11-7. doi: 10.4103/1319-3767.91729.
2
Gastric cancer development after Helicobacter pylori eradication therapy: a new form of gastric neoplasia.幽门螺杆菌根除治疗后的胃癌发展:一种新形式的胃癌。
Digestion. 2012;85(1):61-7. doi: 10.1159/000335260. Epub 2012 Jan 5.
3
A new look at anti-Helicobacter pylori therapy.重新审视抗幽门螺杆菌治疗。
World J Gastroenterol. 2011 Sep 21;17(35):3971-5. doi: 10.3748/wjg.v17.i35.3971.
4
Long-term effect of Helicobacter pylori eradication on the development of metachronous gastric cancer after endoscopic resection of early gastric cancer.早期胃癌内镜切除后,幽门螺杆菌根除对异时性胃癌发展的长期影响。
Gastrointest Endosc. 2012 Jan;75(1):39-46. doi: 10.1016/j.gie.2011.08.030. Epub 2011 Oct 21.
5
Gastric carcinogenesis.胃癌发生。
Langenbecks Arch Surg. 2011 Aug;396(6):729-42. doi: 10.1007/s00423-011-0810-y. Epub 2011 May 25.
6
Helicobacter pylori and gastric cancer.幽门螺杆菌与胃癌
Asian Pac J Cancer Prev. 2010;11(3):583-8.
7
H. pylori infection is a key risk factor for proximal gastric cancer.幽门螺杆菌感染是近端胃癌的一个关键危险因素。
Dig Dis Sci. 2010 Nov;55(11):3124-31. doi: 10.1007/s10620-010-1351-x. Epub 2010 Jul 29.
8
Role of Helicobacter pylori infection in gastric cancer pathogenesis: a chance for prevention.幽门螺杆菌感染在胃癌发病机制中的作用:预防的机会。
J Dig Dis. 2010 Feb;11(1):2-11. doi: 10.1111/j.1751-2980.2009.00408.x.
9
Efficacy of H. pylori eradication with a sequential regimen followed by rescue therapy in clinical practice.序贯疗法后补救治疗在临床实践中根除 H. pylori 的疗效。
Dig Liver Dis. 2010 Aug;42(8):541-3. doi: 10.1016/j.dld.2009.12.007. Epub 2010 Jan 12.
10
Helicobacter pylori and gastric adenocarcinoma.幽门螺杆菌与胃腺癌。
Clin Microbiol Infect. 2009 Nov;15(11):971-6. doi: 10.1111/j.1469-0691.2009.03031.x.